Ballentine Partners »

Abcellera Biologics shares owned by Ballentine Partners

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Ballentine Partners from 13F filings

Historical chart of Ballentine Partners investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Ballentine Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Ballentine Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $54k 21k 2.60

More positions owned by Ballentine Partners

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Core Msci Emkt (IEMG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Rus 1000 Etf (IWB)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Ballentine Partners

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Baillie Gifford & Co
Ing Investment Management
OrbiMed Advisors
Arrowpoint Asset Management
BlackRock
BlackRock
Renaissance Technologies
Tang Capital Management
Federated Investors
Two Sigma Investments
Guardian Capital Advisors
Two Sigma Advisers
Citadel Advisors
Novo A/S

View all funds holding Abcellera Biologics